XMD17-51

Uses

5,11-Dihydro-5,11-dimethyl-2-[[1-(4-piperidinyl)-1H-pyrazol-4-yl]amino]-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one is useful for preparing pyrimido-??diazepinone compounds for treating disorders. A highly selective inhibitor of NUAK1.